MCID: ALX002
MIFTS: 37

Alexithymia malady

Category: Mental diseases

Aliases & Classifications for Alexithymia

About this section

Aliases & Descriptions for Alexithymia:

Name: Alexithymia 11 13

Classifications:



External Ids:

Disease Ontology11 DOID:0060131

Summaries for Alexithymia

About this section
Wikipedia:70 Alexithymia /ˌeɪlɛksəˈθaɪmiə/ (also known as Catalinithymia) is a personality construct... more...

MalaCards based summary: Alexithymia is related to antisocial personality disorder and schizophrenia. An important gene associated with Alexithymia is ANKK1 (Ankyrin Repeat And Kinase Domain Containing 1), and among its related pathways are Paroxetine Pathway, Pharmacokinetics and Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics. Affiliated tissues include brain, breast and testes.

Disease Ontology:11 An agnosia that is a deficiency in understanding, processing, or describing emotions.

Related Diseases for Alexithymia

About this section

Diseases related to Alexithymia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 162)
idRelated DiseaseScoreTop Affiliating Genes
1antisocial personality disorder29.6ANKK1, DRD2
2schizophrenia28.1COMT, CRP, DRD2, HTR1A, SLC6A4
3social emotional agnosia10.8
4neurodegeneration with optic atrophy, childhood onset10.5COMT, SLC6A4
5lymphocytic colitis10.5IL4, SLC6A4
6vogt-koyanagi-harada disease10.4COMT, SLC6A4
7histiocytoid hemangioma10.4COMT, IL4
8basal cell carcinoma10.4DRD2, SLC6A4
9adenosine monophosphate deaminase 1 deficiency10.4COMT, OXTR
10splenic disease10.4DRD2, SLC6A4
11erysipelas10.3COMT, DRD2
12lipedematous scalp10.3COMT, DRD2
13intermittent explosive disorder10.3DRD2, SLC6A4
14familial partial lipodystrophy10.3OXTR, SLC6A4
15bladder mixed adenocarcinoma10.3DRD2, SLC6A4
16hypertropia10.3COMT, DRD2
17hallucinogen dependence10.3DRD2, SLC6A4
18spondylosis10.3CRP, IL4
19brain meningioma10.2COMT, DRD2
20acute female pelvic peritonitis10.2ANKK1, DRD2
21pelvic inflammatory disease10.2DRD2, SLC6A4
22esophagus melanoma10.2CRP, IL4
23loeffler syndrome10.2CRP, IL4
24opportunistic bacterial infectious disease10.2CRP, IL4
25diabetic encephalopathy10.2CRP, SLC6A4
26mandibular cancer10.1CRP, IL4
27dentin caries10.1IL4, TAS2R38
28acinar cell carcinoma10.1DRD2, SLC6A4
29hemorrhagic cystitis10.1COMT, DRD2, SLC6A4
30ulcerative colitis10.1COMT, DRD2, SLC6A4
31conjunctival degeneration10.1HTR1A, SLC6A4
32idiopathic neonatal atrial flutter10.1HTR1A, SLC6A4
33maternal uniparental disomy of chromosome 1310.1COMT, DRD2, SLC6A4
34vestibular nystagmus10.1CRP, IL4
35nonencapsulated sclerosing carcinoma10.1HTR1A, SLC6A4
36lymphosarcoma10.1COMT, DRD2, SLC6A4
37vulvar disease10.1COMT, DRD2, SLC6A4
38central sleep apnea10.1HTR1A, SLC6A4
39personality disorder10.1
40dental fluorosis10.1HTR1A, SLC6A4
41pyromania10.1HTR1A, SLC6A4
42malignant peripheral nerve sheath tumor10.1HTR1A, SLC6A4
43eating disorder10.1
44hemorrhagic fever with renal syndrome10.0CRP, IL4
45mixed malaria10.0HTR1A, SLC6A4
46heroin dependence10.0ANKK1, DRD2, SLC6A4
47alcoholic liver cirrhosis10.0ANKK1, DRD2, SLC6A4
48xanthomatosis10.0CRP, IL4
49viral gastritis10.0HTR1A, SLC6A4
50somatoform disorder10.0

Graphical network of the top 20 diseases related to Alexithymia:



Diseases related to alexithymia

Symptoms for Alexithymia

About this section

Drugs & Therapeutics for Alexithymia

About this section

Drugs for Alexithymia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SertralineapprovedPhase 429579617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
CP 51974
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-Sertraline
sertraline
sertraline (Zoloft)
2Serotonin AgentsPhase 4, Phase 23102
3Serotonin Uptake InhibitorsPhase 41570
4
SerotoninPhase 4, Phase 2356650-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
5Psychotropic DrugsPhase 4, Phase 26279
6Neurotransmitter AgentsPhase 4, Phase 217734
7Neurotransmitter Uptake InhibitorsPhase 4, Phase 23464
8Antidepressive AgentsPhase 42666
9
Oxytocinapproved, vet_approvedPhase 240850-56-6439302, 53477758
Synonyms:
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
(Arg8)-Vasopressin
(Arg8)-Vasotocin
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
50-56-6
AC1L9735
Argipressin
Argpressin Acetate
BCBcMAP01_000094
Biotinyl-(Arg8)-Vasopressin
C00746
CHEBI:492195
CHEBI:7872
CHEMBL395429
CID439302
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
D00089
Disulfide bridge Cys1-Cys6
Gly-Leu-Pro-c
HS-2021
 
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
MolPort-003-938-941
NCGC00167132-01
O3251_SIGMA
O4375_SIGMA
OXT
OXYTOCIN
Ocytocin
Oxitocina
Oxytocic hormone
Oxytocin (JP15/USP/INN)
Oxytocin (TN)
Oxytocin 10 Usp Units In Dextrose 5%
Oxytocin 20 Usp Units In Dextrose 5%
Oxytocin 5 Usp Units In Dextrose 5%
Oxytocin Acetate
Oxytocin injection
Oxytocine
Oxytocinum
Pitocin
Pitocin (TN)
Syntocinon
Syntocinon (TN)
TI-001
alpha-Hypophamine
nchembio.184-comp2
10
3,4-Methylenedioxyamphetamineexperimental, illicitPhase 2334764-17-41614
Synonyms:
(RS)-3,4-(methylenedioxy)methamphetamine
1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine
1-(1,3-Benzodioxol-5-yl)-N-methylpropan-2-amine
3,4-Methylenedioxymethamphetamine
 
DL-(3,4-Methylenedioxy)methamphetamine
MDMA
N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine
N-Methyl-3,4-methylenedioxyamphetamine
Tenamfetamine
11OxytocicsPhase 2660
12HallucinogensPhase 2173
13N-Methyl-3,4-methylenedioxyamphetaminePhase 236
14Adrenergic AgentsPhase 25140
15
AcetylcysteineapprovedPhase 1316616-91-112035
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
 
Fluprowit
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-ACETYL-L-cysteine
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
16Protective AgentsPhase 17190
17VitaminsPhase 15095
18N-monoacetylcystinePhase 1316
19Respiratory System AgentsPhase 14818
20AntioxidantsPhase 12928
21ExpectorantsPhase 1388
22Anti-Infective AgentsPhase 121402
23AntidotesPhase 11038
24Antiviral AgentsPhase 19732
25
Hydrocortisoneapproved, vet_approved64050-23-75754, 657311
Synonyms:
(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
11-Hydrocortisone
11-beta-Hydrocortisone
11-beta-Hydroxycortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b-Hydrocortisone
11b-Hydroxycortisone
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11beta-Hydroxycortisone
11beta-hydrocortisone
11β-hydrocortisone
17-Hydroxycorticosterone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
2v95
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
AI3-25006
AKOS001582651
Acticort
Acticort (TN)
Aeroseb HC
Aeroseb-HC
Ala-Cort
Ala-Scalp
Alacort
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Aquacort
Aquanil HC
B48448A1-24BA-47CA-8D9E-43E5BC949386
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
Balneol-hc
Barseb HC
Basan-Corti
Beta-hc
Bio-0648
C00735
C21H30O5
CCRIS 5854
CHEBI:17650
CHEMBL389621
CID5754
COR-OTICIN
CPD000653523
CaldeCORT Spray
Cetacort
Chronocort
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
Compound F
Compound F (kendall)
Cor-Tar-Quin
Corhydron
Cort-Dome
Cort-Quin
Cortanal
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisporin
Cortisporin Otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cortril
Cremesone
Cremicort-H
Cutisol
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Derm-Aid
Dermacort
Dermaspray
Dermil
Dermocortal
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
DuoCort
EINECS 200-020-1
EU-0100594
Ef corlin
Efcorbin
Efcortelan
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
Evacort
Ficortril
Fiocortril
Flexicort
Foille Insetti
Genacort
Genacort (lotion)
Glycort
Gyno-Cortisone
H 4001
H-Cort
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
H4001_SIGMA
H6909_SIGMA
HC
HC #1
 
HC #4
HC (HYDROCORTISONE)
HMS1569I16
HMS2090M04
HSDB 3339
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE IN ABSORBASE
Heb Cort
Heb-Cort
Hi-cor
Hidalone
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
Hydro-Adreson
Hydro-Colisona
Hydro-RX
Hydro-colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone Acetate
Hydrocortisone Base
Hydrocortisone Butyrate
Hydrocortisone Sodium Phosphate
Hydrocortisone Valerate
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone free alcohol
Hydrocortisone solution
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Kendall'S compound F
Kendall's compound F
Komed HC
Kyypakkaus
LMST02030001
LS-7439
Lacticare HC
Lacticare-HC
Lactisona
Lopac0_000594
Lubricort
MLS000069609
MLS001148103
MLS002207135
MLS002222189
Maintasone
Medicort
Meusicort
Mildison
Milliderm
MolPort-001-794-637
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
NSC 10483
NSC-10483
NSC10483
Neo-Cort-Dome
Neo-Cortef
Neosporin-H Ear
Nogenic HC
Nutracort
Nystaform-HC
ORLEX HC
Optef
Otalgine
Otic-Neo-Cort-Dome
Otobiotic
Otocort
Otosone-F
Pediotic Suspension
Penecort
Permicort
Polcort H
Preparation H Hydrocortisone Cream
Prepcort
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prestwick_265
Prevex HC
Proctocort
Proctofoam
Proctozone HC
Protocort
Racet
Rectasol-HC
Rectoid
Reichstein'S substance M
Reichstein's substance M
Remederm HC
S1696_Selleck
SAM002264617
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Sanatison
Scalp-Cort
Scalpicin Capilar
Schericur
Scheroson F
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral Hydrocort
Tarcortin
Texacort
Texacort lotion 25
Timocort
Topicort
Transderma H
Traumaide
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Uniderm
Vioform-Hydrocortisone
VoSol HC
Vytone
Zenoxone
[3H]cortisol
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
hydrocortisone
26
Dopamineapproved375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
27
Norepinephrineapproved68351-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
28Duloxetine Hydrochloride264
29Peripheral Nervous System Agents22776
30Serotonin and Noradrenaline Reuptake Inhibitors450
31Dopamine Agents3759
32Hydrocortisone 17-butyrate 21-propionate640
33Anti-Inflammatory Agents10355
34Cortisol succinate640
35Hydrocortisone acetate640
36Analgesics11287

Interventional clinical trials:

(show all 28)
idNameStatusNCT IDPhase
1Clinical Assessment and Psychosocial Impact of PsoriasisCompletedNCT01964443Phase 4
2Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress DisorderCompletedNCT00391430Phase 4
3Pain and Stress Management for FibromyalgiaCompletedNCT01287481Phase 2
4Ocytocine and Cerebral Activation in Relation With AttachementRecruitingNCT02847143Phase 2
5MDMA-assisted Therapy for Social Anxiety in Autistic AdultsActive, not recruitingNCT02008396Phase 2
6Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in AdolescentsCompletedNCT01111734Phase 1
7Neurobiological, Neuropsychological,Linguistic and Gestural Processes and Phenomena in Individuals With AlexithymiaUnknown statusNCT00830752
8Psychological Impact in Diabetes: Intervention With Affect School and Basal Body AwarenessUnknown statusNCT01498614
9Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to DementiaUnknown statusNCT01436552
10The Emotion Builder: An Intervention for Emotional Deficits After Brain InjuryCompletedNCT02432300
11Online Treatment of TrichotillomaniaCompletedNCT02044237
12Moderating Impact of Various Emotion Personality Factors on Salivary Cortisol Response to a TSSTCompletedNCT00451126
13Effectiveness of Standard Emergency Department Psychiatric Treatment Associated With Treatment Delivery by a Suicide Prevention CenterCompletedNCT00641498
14Attention Bias Modification Treatment for Warzone-Related Posttraumatic Stress Disorder (PTSD)CompletedNCT01564667
15Service Member Fatigue and Lack of Motivation Following ConcussionCompletedNCT01496586
16Functional Neuroanatomy and Regional Metabolism Before and After Treatment With DuloxetineCompletedNCT02658617
17Depression Online Assessment and TherapyCompletedNCT02112266
18Stress Management for Irritable Bowel SyndromeCompletedNCT01886027
19Plasticity of the Compassionate BrainCompletedNCT01833104
20Positive Emotion Regulation Training in Children, Adolescents and Young Adults With and Without Developmental DisorderRecruitingNCT02898298
21A SYNdemic BASed INtervention for MSM With High Risk Behavior: Design of a Randomized Controlled TrialRecruitingNCT02859935
22Mental Training for CFS Following EBV Infection in AdolescentsRecruitingNCT02499302
23Oculomotor Markers and Attachment in AdolescentsRecruitingNCT02851810
24Randomized Controlled Study of the Efficacy of Hypnosis Versus Relaxation and Control in Neuropathic PainRecruitingNCT02256371
25Student Outcomes of Integrative Mental Health ServicesRecruitingNCT02877875
26Halifax Treatment Refractory Depression TrialActive, not recruitingNCT01141426
27Mindfulness for Irritable Bowel SyndromeActive, not recruitingNCT02794376
28Psychological Variables and Hyperglycemia in Diabetes MellitusEnrolling by invitationNCT01714986

Search NIH Clinical Center for Alexithymia

Genetic Tests for Alexithymia

About this section

Anatomical Context for Alexithymia

About this section

MalaCards organs/tissues related to Alexithymia:

35
Brain, Breast, Testes, Cortex, Heart, Skin, Thyroid

Animal Models for Alexithymia or affiliated genes

About this section

Publications for Alexithymia

About this section

Articles related to Alexithymia:

(show top 50)    (show all 637)
idTitleAuthorsYear
1
Alexithymia, but not autism spectrum disorder, may be related to the production of emotional facial expressions. (27895883)
2016
2
Alexithymia and psychopathological symptoms in adolescent outpatients and mothers suffering from migraines: a case control study. (27093870)
2016
3
Association between the Catechol-O-Methyltransferase (COMT) ValA^a8/a8,Met Polymorphism and Alexithymia in Patients with Obsessive-Compulsive Disorder. (26996573)
2016
4
Default Mode Network alterations in alexithymia: an EEG power spectra and connectivity study. (27845326)
2016
5
Investigation of facial emotion recognition, alexithymia, and levels of anxiety and depression in patients with somatic symptoms and related disorders. (27199559)
2016
6
Apathy, alexithymia, and depressive symptoms: Points of convergence and divergence. (27512920)
2016
7
Affective agnosia: Expansion of the alexithymia construct and a new opportunity to integrate and extend Freud's legacy. (26054794)
2015
8
Live happily live in hiding (from our affect): Alexithymia Influences affect intensity and affect frequency ratings in men. (26506016)
2015
9
Dissociation between Emotional Remapping of Fear and Disgust in Alexithymia. (26462241)
2015
10
Common and distinct impacts of autistic traits and alexithymia on social reward. (25853670)
2015
11
Caffeine use and alexithymia in university students. (25188705)
2014
12
Alexithymia impact on type 1 and type 2 diabetes: a case-control study. (25148784)
2014
13
Distinct associations of insula and cingulate volume with the cognitive and affective dimensions of alexithymia. (24334109)
2013
14
Alexithymia and personality in relation to social anxiety among university students. (23246382)
2013
15
I don't know how I feel, therefore I act: alexithymia, urgency, and alcohol problems. (23384454)
2013
16
Stress coping strategies in patients with psychogenic non-epileptic seizures and how they relate to trauma symptoms, alexithymia, anger and mood. (23689067)
2013
17
Alexithymia, emotional empathy, and self-regulation in anorexia nervosa. (23638441)
2013
18
Brain response during visual emotional processing: an fMRI study of alexithymia. (23850105)
2013
19
Alexithymia and fibromyalgia: clinical evidence. (24348453)
2013
20
Alexithymia, suicide risk and serum lipid levels among adult outpatients with panic disorder. (23332553)
2013
21
A behavior genetic analysis of trait emotional intelligence and alexithymia: a replication. (23298794)
2013
22
Alexithymia as a mediator between attachment and the development of borderline personality disorder in adolescence. (23013337)
2012
23
Alexithymia in severe idiopathic scoliosis: findings from a cross-sectional study of adolescents who have or have not had operations. (22373771)
2012
24
Associations between facial emotion recognition, cognition and alexithymia in patients with schizophrenia: comparison of photographic and virtual reality presentations. (22954834)
2012
25
Child maltreatment, subsequent non-suicidal self-injury and the mediating roles of dissociation, alexithymia and self-blame. (22858062)
2012
26
Alexithymia is not a stable personality trait in patients with substance use disorders. (22382053)
2012
27
Chronic idiopathic urticaria, psychological co-morbidity and posttraumatic stress: the impact of alexithymia and repression. (22362490)
2012
28
Alexithymia, craving and attachment in a heavy drinking population. (21215527)
2011
29
Impact of childhood trauma, alexithymia, dissociation, and emotion suppression on emotional Stroop task. (21193101)
2011
30
Alexithymia in neurodegenerative disease. (21432723)
2011
31
Parental bonding and alexithymia: a meta-analysis. (21277748)
2011
32
Alexithymia in juvenile primary headache sufferers: a pilot study. (20730593)
2011
33
Alexithymia and temperament and character model of personality in patients with major depressive disorder. (19932828)
2010
34
Commentary on the paper "Is alexithymia a risk factor for major depression, personality disorder, or alcohol use disorders? A prospective population-based study". (20159213)
2010
35
Individual differences in alexithymia and brain response to masked emotion faces. (19524887)
2010
36
Alexithymia, emotion processing and social anxiety in adults with ADHD. (20952350)
2010
37
Alexithymia, temperament and character as predictors of psychopathology in patients with major depression. (19084277)
2009
38
Alexithymia and fear of pain independently predict heat pain intensity ratings among undergraduate university students. (19714270)
2009
39
Alexithymia and pathological gambling. (20155587)
2009
40
Alexithymia in severely obese patients seeking surgical treatment. (20099557)
2009
41
Alexithymia and therapist reactions to the patient: expression of positive emotion as a mediator. (18834276)
2008
42
Self-injurious behaviour, traumatic life events and alexithymia among treatment-seeking opiate addicts: prevalence, pattern and correlates. (18639391)
2008
43
Latent structure of the alexithymia construct: a taxometric investigation. (19086762)
2008
44
The construct of alexithymia: associations with defense mechanisms. (18302210)
2008
45
Alexithymia, somatization and negative affect in a community sample. (17258817)
2007
46
Assessing alexithymia and type A behavior in coronary heart disease patients: a multimethod approach. (17426418)
2007
47
An evaluation of the absolute and relative stability of alexithymia in women with breast cancer. (17540221)
2007
48
Response to "Letter to the Editor: The overlap between alexithymia and Asperger's syndrome", Fitzgerald and Bellgrove, Journal of Autism and Developmental Disorders, 36(4). (17080269)
2006
49
Alexithymia and PTSD symptoms in urban police officers: cross-sectional and prospective findings. (16788996)
2006
50
A preliminary investigation of alexithymia in men with psychoactive substance dependence. (2386256)
1990

Variations for Alexithymia

About this section

Expression for genes affiliated with Alexithymia

About this section
Search GEO for disease gene expression data for Alexithymia.

GO Terms for genes affiliated with Alexithymia

About this section

Biological processes related to Alexithymia according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1sperm ejaculationGO:004271310.4OXTR, SLC6A4
2vasoconstrictionGO:00423109.9HTR1A, SLC6A4
3response to cocaineGO:00422209.8DRD2, OXTR
4response to amphetamineGO:00019759.6DRD2, OXTR
5dopamine metabolic processGO:00424179.6COMT, DRD2
6female pregnancyGO:00075659.5COMT, IL4, OXTR
7response to organic cyclic compoundGO:00140709.5COMT, IL4, OXTR
8social behaviorGO:00351769.5OXTR, SLC6A4
9G-protein coupled receptor signaling pathwayGO:00071868.4DRD2, HTR1A, OXTR, TAS2R38
10response to drugGO:00424938.3COMT, DRD2, IL4, OXTR, SLC6A4

Sources for Alexithymia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet